Characterization of vertigo and hearing loss in patients with Fabry disease
Abstract Background Fabry Disease (FD) is an X-linked hereditary lysosomal storage disorder which leads to a multisystemic intralysosomal accumulation of globotriaosylceramid (Gb3). Besides prominent renal and cardiac organ involvement, patients commonly complain about vestibulocochlear symptoms lik...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-018-0882-7 |
id |
doaj-b9b7c8b5b8d7471790f3fba9ce62557e |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Maria Köping Wafaa Shehata-Dieler Dieter Schneider Mario Cebulla Daniel Oder Jonas Müntze Peter Nordbeck Christoph Wanner Rudolf Hagen Sebastian P. Schraven |
spellingShingle |
Maria Köping Wafaa Shehata-Dieler Dieter Schneider Mario Cebulla Daniel Oder Jonas Müntze Peter Nordbeck Christoph Wanner Rudolf Hagen Sebastian P. Schraven Characterization of vertigo and hearing loss in patients with Fabry disease Orphanet Journal of Rare Diseases Fabry disease Vertigo VEMP Cardiomyopathy Chronic kidney disease Lysosomal storage disorder |
author_facet |
Maria Köping Wafaa Shehata-Dieler Dieter Schneider Mario Cebulla Daniel Oder Jonas Müntze Peter Nordbeck Christoph Wanner Rudolf Hagen Sebastian P. Schraven |
author_sort |
Maria Köping |
title |
Characterization of vertigo and hearing loss in patients with Fabry disease |
title_short |
Characterization of vertigo and hearing loss in patients with Fabry disease |
title_full |
Characterization of vertigo and hearing loss in patients with Fabry disease |
title_fullStr |
Characterization of vertigo and hearing loss in patients with Fabry disease |
title_full_unstemmed |
Characterization of vertigo and hearing loss in patients with Fabry disease |
title_sort |
characterization of vertigo and hearing loss in patients with fabry disease |
publisher |
BMC |
series |
Orphanet Journal of Rare Diseases |
issn |
1750-1172 |
publishDate |
2018-08-01 |
description |
Abstract Background Fabry Disease (FD) is an X-linked hereditary lysosomal storage disorder which leads to a multisystemic intralysosomal accumulation of globotriaosylceramid (Gb3). Besides prominent renal and cardiac organ involvement, patients commonly complain about vestibulocochlear symptoms like high-frequency hearing loss, tinnitus and vertigo. However, comprehensive data especially on vertigo remain scarce. The aim of this study was to examine the prevalence and characteristics of vertigo and hearing loss in patients with FD, depending on renal and cardiac parameters and get hints about the site and the pattern of the lesions. Methods Single-center study with 57 FD patients. Every patient underwent an oto-rhino-laryngological examination as well as videonystagmography and vestibular evoked myogenic potentials (VEMPs) and audiological measurements using pure tone audiometry and auditory brainstem response audiometry (ABR). Renal function was measured by eGFR, cardiac impairment was graduated by NYHA class. Results More than one out of three patients (35.1%) complained about hearing loss, 54.4% about vertigo and 28.1% about both symptom. In 74% a sensorineural hearing loss of at least 25 dB was found, ABR could exclude any retrocochlear lesion. Caloric testing showed abnormal values in 71.9%, VEMPs were pathological in 68%. A correlation between the side or the shape of hearing loss and pathological vestibular testing could not be revealed. Conclusions Hearing loss and vertigo show a high prevalence in FD. While hearing loss seems due to a cochlear lesion, peripheral vestibular as well as central nervous pathologies cause vertigo. Thus, both the site of lesion and the pathophysiological patterns seem to differ. |
topic |
Fabry disease Vertigo VEMP Cardiomyopathy Chronic kidney disease Lysosomal storage disorder |
url |
http://link.springer.com/article/10.1186/s13023-018-0882-7 |
work_keys_str_mv |
AT mariakoping characterizationofvertigoandhearinglossinpatientswithfabrydisease AT wafaashehatadieler characterizationofvertigoandhearinglossinpatientswithfabrydisease AT dieterschneider characterizationofvertigoandhearinglossinpatientswithfabrydisease AT mariocebulla characterizationofvertigoandhearinglossinpatientswithfabrydisease AT danieloder characterizationofvertigoandhearinglossinpatientswithfabrydisease AT jonasmuntze characterizationofvertigoandhearinglossinpatientswithfabrydisease AT peternordbeck characterizationofvertigoandhearinglossinpatientswithfabrydisease AT christophwanner characterizationofvertigoandhearinglossinpatientswithfabrydisease AT rudolfhagen characterizationofvertigoandhearinglossinpatientswithfabrydisease AT sebastianpschraven characterizationofvertigoandhearinglossinpatientswithfabrydisease |
_version_ |
1724929637935480832 |
spelling |
doaj-b9b7c8b5b8d7471790f3fba9ce62557e2020-11-25T02:07:48ZengBMCOrphanet Journal of Rare Diseases1750-11722018-08-011311910.1186/s13023-018-0882-7Characterization of vertigo and hearing loss in patients with Fabry diseaseMaria Köping0Wafaa Shehata-Dieler1Dieter Schneider2Mario Cebulla3Daniel Oder4Jonas Müntze5Peter Nordbeck6Christoph Wanner7Rudolf Hagen8Sebastian P. Schraven9Department of Oto-Rhino-Laryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, Comprehensive Hearing Center (CHC) and Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital WürzburgDepartment of Oto-Rhino-Laryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, Comprehensive Hearing Center (CHC) and Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital WürzburgDepartment of Oto-Rhino-Laryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, Comprehensive Hearing Center (CHC) and Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital WürzburgDepartment of Oto-Rhino-Laryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, Comprehensive Hearing Center (CHC) and Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital WürzburgDepartment of Internal Medicine I, Comprehensive Heart Failure Center (CHFC) and Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital WürzburgDepartment of Internal Medicine I, Comprehensive Heart Failure Center (CHFC) and Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital WürzburgDepartment of Internal Medicine I, Comprehensive Heart Failure Center (CHFC) and Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital WürzburgDepartment of Internal Medicine I, Comprehensive Heart Failure Center (CHFC) and Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital WürzburgDepartment of Oto-Rhino-Laryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, Comprehensive Hearing Center (CHC) and Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital WürzburgDepartment of Otorhinolaryngology, Head and Neck Surgery “Otto Körner”, University Medical Center RostockAbstract Background Fabry Disease (FD) is an X-linked hereditary lysosomal storage disorder which leads to a multisystemic intralysosomal accumulation of globotriaosylceramid (Gb3). Besides prominent renal and cardiac organ involvement, patients commonly complain about vestibulocochlear symptoms like high-frequency hearing loss, tinnitus and vertigo. However, comprehensive data especially on vertigo remain scarce. The aim of this study was to examine the prevalence and characteristics of vertigo and hearing loss in patients with FD, depending on renal and cardiac parameters and get hints about the site and the pattern of the lesions. Methods Single-center study with 57 FD patients. Every patient underwent an oto-rhino-laryngological examination as well as videonystagmography and vestibular evoked myogenic potentials (VEMPs) and audiological measurements using pure tone audiometry and auditory brainstem response audiometry (ABR). Renal function was measured by eGFR, cardiac impairment was graduated by NYHA class. Results More than one out of three patients (35.1%) complained about hearing loss, 54.4% about vertigo and 28.1% about both symptom. In 74% a sensorineural hearing loss of at least 25 dB was found, ABR could exclude any retrocochlear lesion. Caloric testing showed abnormal values in 71.9%, VEMPs were pathological in 68%. A correlation between the side or the shape of hearing loss and pathological vestibular testing could not be revealed. Conclusions Hearing loss and vertigo show a high prevalence in FD. While hearing loss seems due to a cochlear lesion, peripheral vestibular as well as central nervous pathologies cause vertigo. Thus, both the site of lesion and the pathophysiological patterns seem to differ.http://link.springer.com/article/10.1186/s13023-018-0882-7Fabry diseaseVertigoVEMPCardiomyopathyChronic kidney diseaseLysosomal storage disorder |